Therapeutic promise of JNK ATP-noncompetitive inhibitors

This publication has 63 references indexed in Scilit:

• Inhibition of c‐Jun N‐terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats
  British Journal of Pharmacology, 2004
• AS601245 (1,3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): A c-Jun NH2-Terminal Protein Kinase Inhibitor with Neuroprotective Properties
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
  Current Pharmaceutical Design, 2004
• Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
  Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2004
• The Structure of JNK3 in Complex with Small Molecule Inhibitors
  Chemistry & Biology, 2003
• Targeting JNK for therapeutic benefit: from junk to gold?
  Nature Reviews Drug Discovery, 2003
• The specificities of protein kinase inhibitors: an update
  Biochemical Journal, 2003
• The Protein Kinase Complement of the Human Genome
  Science, 2002
• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
  Proceedings of the National Academy of Sciences, 2001
• A Mammalian Scaffold Complex That Selectively Mediates MAP Kinase Activation
  Science, 1998